Rebecca Araujo
Articles by Rebecca Araujo
The use of ADHD medications may be linked to an increased risk of cardiovascular disease.
Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure.
In patients with metastatic nonsquamous NSCLC, pembrolizumab plus chemotherapy showed clinical efficacy.
For patients with breast cancer, a regimen of epirubicin followed by adjuvant chemotherapy is associated with worse QOL.
Treatment with brexpiprazole led to a significant improvement in agitation for patients with dementia due to AD.
A study evaluated the efficacy of psychotherapies for the treatment of generalized anxiety disorder in adults.
Recent safety data significantly impacted prescribing practices for advanced RA therapies among physicians treating veterans.
Younger children with ADHD aren't more likely to have their diagnosis disconfirmed over time than children diagnosed older.
For adults with lupus nephritis, this specific treatment combination improves total remission rate better than others.
Barriers persist in the implementation of universal routine screening for major depressive disorder in adolescents.
Atezolizumab plus bevacizumab improves recurrence-free survival in patients with resected or ablated high-risk HCC.
Bimekizumab demonstrated sustained efficacy for the treatment of active axial spondyloarthritis through 52 weeks.
A novel potassium channel opener was well-tolerated and reduced seizures in patients with focal-onset seizures.
TACE in combination with TKIs and ICIs led to improvements in response and survival in patients with HCC.
A study sought to understand the prognostic ability of 2 angiogenesis mediators to predict poor response to TACE in HCC.
A study evaluated predictors of liver segmental hypertrophy following radiotherapy for metastatic liver cancer.
A treatment combination significantly improved survival for the treatment of HCC in patients who are refractory to TACE.
A study evaluated 6 clinical trials of HER2-targeted regimens of HER2-positive metastatic colorectal cancer.
A study assessed the efficacy of of several adjuvant therapies for hepatocellular carcinoma.
A study assessed whether the addition of anti-VEGF agent to first-line treatment impacted outcomes in metastatic CRC.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.